DNMT3A CHIP

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Rheumatoid arthritis

upin silico1OR 1.24

1 study
  1. Rheumatoid arthritis raises the risk of DNMT3A CHIP in silico (OR 1.24, 95%CI: 1.09-1.41, p=0.001).

    “Only RA was significantly associated with an increased risk (OR 1.24, 95%CI: 1.09-1.41, p=0.001)”

    In silicotwo-sample Mendelian randomization

    The Effects of Autoimmune Rheumatic Diseases on the Development of Clonal Hematopoiesis

    AHA Scientific Sessions 2025 abstract3 Nov 2025

More on Rheumatoid arthritis

Latest

Nov 2025: 2Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 2Sep 2026: 1Oct 2026: 06 in 12 months
medRxiv

ASXL1-mutant clonal hematopoiesis links to aortic valve disease

In cohort data and cell models, ASXL1 mutations tracked with incident aortic stenosis and promoted valvular calcification that was reduced by IL-1 or IL-6 inhibition.In cohort data and cell models, ASXL1 mutations tracked with incident aortic stenosis and promoted valvular calcification that was reduced by IL-1 or IL-6 inhibition.

Preprint: cohort study of 449,109 peopleASXL1